Breaking News, Collaborations & Alliances

Celonic, Carbogen Amcis Partner to Offer Integrated ADC Development & Manufacturing

Alliance creates a seamless, end-to-end platform for ADC innovators.

Author Image

By: Charlie Sternberg

Associate Editor

Dr. Samanta Cimitan, CEO of Celonic Group, and Stephan Fritschi, CEO of Carbogen Amcis Group.

Celonic Group, a “pureplay” Biologics CDMO, and the Carbogen Amcis Group, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, have joined forces to offer a fully integrated Antibody-Drug Conjugate (ADC) development and manufacturing solution. The alliance combines Celonic’s advanced biologics capabilities with CARBOGEN AMCIS’s expertise in payload synthesis, conjugation, and sterile fill-finish, creating a seamless, end-to-end platform for AD...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters